Synchronous lung and multiple soft tissue metastases developed from osteosarcoma of tibia: a rare case report and genetic profile analysis

[1]  Guanzhen Yu,et al.  Metastatic Low-Grade Sarcoma with CARS-ALK Fusion Dramatically Responded to Multiple ALK Tyrosine Kinase Inhibitors: A Case Report with Comprehensive Genomic Analysis. , 2020, The oncologist.

[2]  David M. Thomas,et al.  Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma. , 2020, JAMA oncology.

[3]  Aman N. Patel,et al.  Enrichment of heterozygous germline RECQL4 loss-of-function variants in pediatric osteosarcoma , 2019, Cold Spring Harbor molecular case studies.

[4]  M. Zeng,et al.  ALKATI interacts with c-Myc and promotes cancer stem cell-like properties in sarcoma , 2019, Oncogene.

[5]  Wei Guo,et al.  Apatinib for Advanced Osteosarcoma after Failure of Standard Multimodal Therapy: An Open Label Phase II Clinical Trial. , 2019, The oncologist.

[6]  A. Qureshi,et al.  Cardiovascular recurrence of high-grade osteosarcoma presenting as atrial thrombosis and pulmonary embolism: A case report and review of the pediatric literature , 2019, Pediatric hematology and oncology.

[7]  P. Rosenberg,et al.  Increased risk of colon cancer and osteogenic sarcoma in Diamond-Blackfan anemia. , 2018, Blood.

[8]  Han-Soo Kim,et al.  Postmetastasis survival in high‐grade extremity osteosarcoma: A retrospective analysis of prognostic factors in 126 patients , 2018, Journal of surgical oncology.

[9]  O. Delattre,et al.  Does ATRX germline variation predispose to osteosarcoma? Three additional cases of osteosarcoma in two ATR-X syndrome patients , 2018, European Journal of Human Genetics.

[10]  Publisher's Note , 2018, Anaesthesia.

[11]  J. Takita.  The role of anaplastic lymphoma kinase in pediatric cancers , 2017, Cancer science.

[12]  David M. Thomas,et al.  Phosphoproteomic Profiling Reveals ALK and MET as Novel Actionable Targets across Synovial Sarcoma Subtypes. , 2017, Cancer research.

[13]  M. Lim,et al.  Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  L. Mirabello,et al.  Germline and somatic genetics of osteosarcoma — connecting aetiology, biology and therapy , 2017, Nature Reviews Endocrinology.

[15]  R. Mohankumar,et al.  Magnetic resonance imaging appearance of soft-tissue metastases: our experience at an orthopedic oncology center , 2017, Skeletal Radiology.

[16]  S. Bielack,et al.  Novel insights and therapeutic interventions for pediatric osteosarcoma. , 2017, Future oncology.

[17]  David M. Thomas,et al.  Monogenic and polygenic determinants of sarcoma risk: an international genetic study. , 2016, The Lancet. Oncology.

[18]  Li Ding,et al.  Germline Mutations in Predisposition Genes in Pediatric Cancer. , 2015, The New England journal of medicine.

[19]  P. Meltzer,et al.  Osteosarcoma: Current Treatment and a Collaborative Pathway to Success. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  K. Ohshima,et al.  Anaplastic lymphoma kinase protein expression, genetic abnormalities, and phosphorylation in soft tissue tumors: Phosphorylation is associated with recurrent metastasis. , 2015, Oncology reports.

[21]  Aare Märtson,et al.  Whole exome sequencing of a single osteosarcoma case—integrative analysis with whole transcriptome RNA-seq data , 2014, Human Genomics.

[22]  Adam Kiezun,et al.  Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma , 2014, Proceedings of the National Academy of Sciences.

[23]  Liang Shen,et al.  Ceritinib in ALK-rearranged non-small-cell lung cancer. , 2014, The New England journal of medicine.

[24]  A. Tanimoto,et al.  Metastasis of osteosarcoma to the trapezius muscle: a case report , 2014, World Journal of Surgical Oncology.

[25]  T. Shibata,et al.  Anaplastic lymphoma kinase status in rhabdomyosarcomas , 2013, Modern Pathology.

[26]  M. Assadi,et al.  Metastasis of femoral osteosarcoma to the abdominal wall detected on 99m Tc-MDP skeletal scintigraphy , 2013, Annals of Nuclear Medicine.

[27]  A. Vijayananthan,et al.  Rare occurrence of bilateral breast and peritoneal metastases from osteogenic sarcoma. , 2013, Singapore medical journal.

[28]  M. Olivier,et al.  Sarcomas in TP53 germline mutation carriers , 2012, Cancer.

[29]  A. Pérez‐Martínez,et al.  Unusual Sites of Extrapulmonary Metastases of Osteosarcoma After Several Lines of Treatment , 2011, Pediatric hematology and oncology.

[30]  E. Kontopantelis,et al.  Relationship between height at diagnosis and bone tumours in young people: a meta-analysis , 2011, Cancer Causes & Control.

[31]  Jeffrey W. Clark,et al.  Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. , 2010, The New England journal of medicine.

[32]  Ian D. Hickson,et al.  RecQ helicases: multifunctional genome caretakers , 2009, Nature Reviews Cancer.

[33]  M. Blackstein,et al.  Osteosarcoma in adolescents and adults: survival analysis with and without lung metastases. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[34]  S. Bielack,et al.  Second and subsequent recurrences of osteosarcoma: presentation, treatment, and outcomes of 249 consecutive cooperative osteosarcoma study group patients. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  John M. Maris,et al.  Identification of ALK as a major familial neuroblastoma predisposition gene , 2008, Nature.

[36]  Y. Yatabe,et al.  Osteosarcoma with skeletal muscle metastasis , 2008, Archives of Orthopaedic and Trauma Surgery.

[37]  C. Antonescu,et al.  Osteosarcoma with delayed metastasis to the stomach. , 2007, Journal of pediatric surgery.

[38]  A. Wotherspoon,et al.  Osteosarcoma metastasising to the duodenum and pancreas. , 2007, The Journal of bone and joint surgery. British volume.

[39]  M. Semik,et al.  Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  T. Damron,et al.  Metastasis of Osteosarcoma to Soft Tissue: A Case Report* , 2000, The Journal of bone and joint surgery. American volume.

[41]  A. Giuliano,et al.  Changing metastatic patterns of osteosarcoma , 1984, Cancer.

[42]  M. Mison,et al.  Osteosarcoma. , 2016, Anticancer research.

[43]  V. Radhakrishnan,et al.  Unusual case of extrapulmonary metastatic recurrence in a patient with osteosarcoma. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  C. Beauchamp.  Second and Subsequent Recurrences of Osteosarcoma: Presentation, Treatment, and Outcomes of 249 Consecutive Cooperative Osteosarcoma Study Group Patients , 2009 .